Search

everythinglearnresearchcommunity

for

Search:↓

Conditioned media from mesenchymal stem cells show promise for tissue repair and disease treatment, but more research is needed on their safety and effectiveness.

PHAT may improve hair growth better than PRP alone.

PNKP is essential for keeping adult mouse progenitor cells healthy and growing normally.

Fat injections can help regrow hair in stubborn hair loss cases.

Umbilical cord-derived media is safe and effective for hair growth.

Xeno-free three-dimensional stem cell masses are safe and effective for improving blood flow and tissue repair in limb ischemia.

Islamic perspectives in Malaysia raise ethical concerns about using stem cells, especially from embryos, for beauty and medical treatments.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

New treatments for hair loss show promise but need more testing for effectiveness and safety.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

Effective treatments for hair loss include minoxidil, 5α-reductase inhibitors, and personalized combination therapies.

Mesenchymal stem cells can effectively aid skin healing and anti-aging.

PRP therapy is effective and safe for skin conditions like wound healing and hair loss.

Rigenera® effectively improves hair condition in Androgenetic Alopecia, and HairMetrix® tracks progress well.

Exosome therapy shows promise for hair growth with minimal side effects, but more research is needed.

Combining platelet-rich products, biomaterials, and bioactive substances may improve skin treatment, but more research is needed.

Better standardization and transparency in statistical reporting are needed to improve hair care research quality.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Stem cells can improve skin grafts by enhancing blood flow and hair growth.

Nanoemulgels improve skin disorder treatment by delivering drugs more effectively and reducing application frequency.

Antibody treatments show promise for hair loss but need more research.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Exosomes from special stem cells help treat ulcerative colitis by reducing inflammation and stress.

Excess androgens may cause PCOS, not just be a symptom.

JAGGED1 could help regenerate tissues for bone loss and heart damage if delivered correctly.